human phosphokinase arrays Search Results


proteome profiler human phospho-kinase array kit  (Bio-Techne corporation)
98
Bio-Techne corporation proteome profiler human phospho-kinase array kit
Proteome Profiler Human Phospho Kinase Array Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteome profiler human phospho-kinase array kit/product/Bio-Techne corporation
Average 98 stars, based on 1 article reviews
proteome profiler human phospho-kinase array kit - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier
human phosphokinase array  (Labospace Srl)
90
Labospace Srl human phosphokinase array
Role of p38 MAPK in the expression of LOC105374325 in podocytes. A, human <t>phosphokinase</t> array analysis in podocytes treated with ADR (n = 3); B, level of LOC105374325 in podocytes treated with ADR, SB203580, PD098059, MK2206, and TDZD-8 (n = 5); C and D, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with ADR and SB203580 (n = 5); E, level of Bax and Bak protein in podocytes treated with ADR and SB203580 (n = 3); F, flow cytometric analysis of apoptotic cells in podocytes treated with ADR and SB203580 (n = 5); G, immunofluorescence staining of p-p38 in glomerular tissues of FSGS patients and normal controls (n = 5); H, level of p-p38 in podocytes treated with ADR (n = 3); I, level of p-p38 in podocytes transfected with LOC105374325 plasmid (n = 3); J, level of LOC105374325 in podocytes treated with U-46619 (n = 5); K and L, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with U-46619 (n = 5); M, level of Bax and Bak protein in podocytes treated with U-46619 (n = 3); N, flow cytometric analysis of apoptotic cells in podocytes treated with U-46619 (n = 5). For statistical analysis, a two-tailed Student's t test was used for J and N, and one-way ANOVA with Tukey's post hoc test was used for B–D, F, K, and L. *, p < 0.05 compared with control; #, p < 0.05 compared with podocytes treated with ADR. Bar, 20 μm.
Human Phosphokinase Array, supplied by Labospace Srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human phosphokinase array/product/Labospace Srl
Average 90 stars, based on 1 article reviews
human phosphokinase array - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Role of p38 MAPK in the expression of LOC105374325 in podocytes. A, human phosphokinase array analysis in podocytes treated with ADR (n = 3); B, level of LOC105374325 in podocytes treated with ADR, SB203580, PD098059, MK2206, and TDZD-8 (n = 5); C and D, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with ADR and SB203580 (n = 5); E, level of Bax and Bak protein in podocytes treated with ADR and SB203580 (n = 3); F, flow cytometric analysis of apoptotic cells in podocytes treated with ADR and SB203580 (n = 5); G, immunofluorescence staining of p-p38 in glomerular tissues of FSGS patients and normal controls (n = 5); H, level of p-p38 in podocytes treated with ADR (n = 3); I, level of p-p38 in podocytes transfected with LOC105374325 plasmid (n = 3); J, level of LOC105374325 in podocytes treated with U-46619 (n = 5); K and L, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with U-46619 (n = 5); M, level of Bax and Bak protein in podocytes treated with U-46619 (n = 3); N, flow cytometric analysis of apoptotic cells in podocytes treated with U-46619 (n = 5). For statistical analysis, a two-tailed Student's t test was used for J and N, and one-way ANOVA with Tukey's post hoc test was used for B–D, F, K, and L. *, p < 0.05 compared with control; #, p < 0.05 compared with podocytes treated with ADR. Bar, 20 μm.

Journal: The Journal of Biological Chemistry

Article Title: The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis

doi: 10.1074/jbc.RA118.005579

Figure Lengend Snippet: Role of p38 MAPK in the expression of LOC105374325 in podocytes. A, human phosphokinase array analysis in podocytes treated with ADR (n = 3); B, level of LOC105374325 in podocytes treated with ADR, SB203580, PD098059, MK2206, and TDZD-8 (n = 5); C and D, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with ADR and SB203580 (n = 5); E, level of Bax and Bak protein in podocytes treated with ADR and SB203580 (n = 3); F, flow cytometric analysis of apoptotic cells in podocytes treated with ADR and SB203580 (n = 5); G, immunofluorescence staining of p-p38 in glomerular tissues of FSGS patients and normal controls (n = 5); H, level of p-p38 in podocytes treated with ADR (n = 3); I, level of p-p38 in podocytes transfected with LOC105374325 plasmid (n = 3); J, level of LOC105374325 in podocytes treated with U-46619 (n = 5); K and L, RNA pulldown and RT-PCR analysis of the LOC105374325–miR-34c and LOC105374325–miR-196a/b complexes in podocytes treated with U-46619 (n = 5); M, level of Bax and Bak protein in podocytes treated with U-46619 (n = 3); N, flow cytometric analysis of apoptotic cells in podocytes treated with U-46619 (n = 5). For statistical analysis, a two-tailed Student's t test was used for J and N, and one-way ANOVA with Tukey's post hoc test was used for B–D, F, K, and L. *, p < 0.05 compared with control; #, p < 0.05 compared with podocytes treated with ADR. Bar, 20 μm.

Article Snippet: Human phosphokinase array analysis The relative phosphorylation level of AKT1(Ser-473), ERK(Thr-202/Tyr-204), GSK3β(Ser-9), JNK(Thr-183/Tyr-185), p38(Thr-180/Tyr-182), p70-S6(Thr-421/Ser-424), and Src(Tyr-416) in ADR-treated podocytes were measured by human phosphokinase array (Phospho RTK4, Labospace, Milano, Italy).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Immunofluorescence, Staining, Transfection, Plasmid Preparation, Two Tailed Test, Control